Evidence map›Paper›PMID 30487429›Full record

ArticleInternational journal of molecular sciences2018

Differentially-Expressed miRNAs in Ectopic Stromal Cells Contribute to Endometriosis Development: The Plausible Role of miR-139-5p and miR-375.

Kadri Rekker, Tõnis Tasa, Merli Saare, Külli Samuel, Ülle Kadastik, Helle Karro, Martin Götte, Andres Salumets, Maire Peters

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
5.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it, 44 citations in OpenAlex.

  1. Expression ofInternational journal of molecular sciences · 2023
    Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Downregulation ofInternational journal of molecular sciences · 2023
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 3 countries.

Kadri RekkerDepartment of Obstetrics and Gynecology, Institute of Clinical Medicine, University of Tartu, 50090 Tartu, Estonia. kadri.rekker@gmail.com.
Tõnis TasaInstitute of Computer Science, University of Tartu, 50090 Tartu, Estonia. ttasa@ut.ee.ORCID 0000-0001-7754-6413
Merli SaareDepartment of Obstetrics and Gynecology, Institute of Clinical Medicine, University of Tartu, 50090 Tartu, Estonia. merli.saare@ut.ee.
Külli SamuelCompetence Centre on Health Technologies, 50410 Tartu, Estonia. kylli.samuel@ccht.ee.
Ülle KadastikTartu University Hospital's Women's Clinic, 50406 Tartu, Estonia. ylle.kadastik@kliinikum.ee.
Helle KarroDepartment of Obstetrics and Gynecology, Institute of Clinical Medicine, University of Tartu, 50090 Tartu, Estonia. helle.karro@kliinikum.ee.
Martin GötteDepartment of Gynecology and Obstetrics, University of Münster, 48149 Münster, Germany. martin.goette@ukmuenster.de.ORCID 0000-0003-2360-2496
Andres SalumetsDepartment of Obstetrics and Gynecology, Institute of Clinical Medicine, University of Tartu, 50090 Tartu, Estonia. andres.salumets@ccht.ee.
Maire PetersDepartment of Obstetrics and Gynecology, Institute of Clinical Medicine, University of Tartu, 50090 Tartu, Estonia. maire.peters@ut.ee.
Competence Centre on Health Technologies (Estonia) · EETartu University Hospital · EEUniversity of Helsinki · FIUniversity of Münster · DEUniversity of Tartu · EE

Funding

Enterprise Estonia EU48695Estonian Ministry of Education and Research IUT34-16European Commission Horizon 2020 research and innovation programme 692065 (WIDENLIFE)MSCA-RISE-2015 691058 (MOMENDO)University of Tartu base funding
6 · The paper itself

Abstract

microRNA (miRNA) expression level alterations between endometrial tissue and endometriotic lesions indicate their involvement in endometriosis pathogenesis. However, as both endometrium and endometriotic lesions consist of different cell types in various proportions, it is not clear which cells contribute to variability in miRNA levels and the overall knowledge about cell-type specific miRNA expression in ectopic cells is scarce. Therefore, we utilized fluorescence-activated cell sorting to isolate endometrial stromal cells from paired endometrial and endometrioma biopsies and combined it with high-throughput sequencing to determine miRNA alterations in endometriotic stroma. The analysis revealed 149 abnormally expressed miRNAs in endometriotic lesions, including extensive upregulation of miR-139-5p and downregulation of miR-375 compared to eutopic cells. miRNA transfection experiments in the endometrial stromal cell line ST-T1b showed that the overexpression of miR-139-5p resulted in the downregulation of homeobox A9 (

Indexed as

EndometriosisEndometriumFemaleHumansMicroRNAsStromal CellsMicroRNAsMIRN139 microRNA, humanMIRN375 microRNA, humanectopic stromaEDN1endometriosisHOXA10microRNAmiR-139-5pmiR-375small RNA sequencing

Identifiers

PMID30487429
PMCPMC6321240
OpenAlexW2902973302

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.